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Background: Malaria is a potentially lethal illness for which preventive measures are not optimally used among all
travellers. Travellers visiting friends and relatives in their country of origin (VFRs) are known to use
chemoprophylaxis less consistently compared to tourist travellers. In this study, factors explaining the low use of
chemoprophylaxis were pursued to contribute to improving uptake of preventive measures among VFRs.
Methods: Following in-depth interviews with Ghanaians living in Amsterdam, a questionnaire was developed to
assess which behavioural determinants were related to taking preventive measures. The questionnaire was
administered at gates of departing flights from Schiphol International Airport, Amsterdam (the Netherlands) to
Kotoka International Airport, Accra (Ghana).
Results: In total, 154 questionnaires were eligible for analysis. Chemoprophylaxis had been started by 83 (53.9%)
and bought by 93 (60.4%) travellers. Pre-travel advice had been obtained by 104 (67.5%) travellers. Those who
attended the pre-travel clinic and those who incorrectly thought they had been vaccinated against malaria were
more likely to use preventive measures. Young-, business- and long-term travellers, those who had experienced
malaria, and those who thought curing malaria was easier than taking preventive tablets were less likely to use
preventive measures.
Conclusion: Almost half of the VFRs travelling to West Africa had not started chemoprophylaxis; therefore, there is
room for improvement. Risk reduction strategies could aim at improving attendance to travel clinics and focus on
young-, business and long term travellers and VFRs who have experienced malaria during consultation. Risk
reduction strategies should focus on improving self-efficacy and conceptions of response efficacy, including social
environment to aim at creating the positive social context needed.
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In spite of numerous attempts to control malaria, it
remains one of the most important life-threatening infec-
tious diseases worldwide. Annually, an estimated 490,000
to 836,000 people die from malaria [1,2]. In industrial-
ized countries, infections are reported among travellers
returning from endemic areas, with currently approxi-
mately 6,000 reported cases in Europe [3] and 1,700
reported cases in the US, Canada and Australia [4-6].* Correspondence: r.w.wieten@amc.uva.nl
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reproduction in any medium, provided the orThese numbers are collected through passive surveil-
lance and therefore likely to be underestimated. The
heaviest burden lies in West Africa and 42 to 68% of
imported infections are acquired here [7-9]. In the
Netherlands around 240 malaria cases have been
reported annually from 2007–2011 [10]. Travellers to
Ghana contributed most (23%) cases of imported malaria,
followed by Nigeria (14%), The Gambia (7%), Guinea (5%),
and Uganda (4%).
Many travellers visiting African countries are visiting
friends and relatives (VFRs). These VFRs are less likely to
seek pre-travel health advice and have a tendency to use
preventive measures less often compared to travellers withLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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heading to West African countries have a high risk of
contracting malaria [11,12,15,16]. A majority of these
malaria cases could have been prevented with appropriate
malaria preventive measures, such as bed nets, mosquito
repellents and chemoprophylaxis. Therefore, a change
in behaviour by VFRs travelling to West Africa seems
to be required.
Successful behaviour change interventions are dependent
on the ability to influence determinants affecting behaviour.
Several determinants have been identified as predictors
for taking prophylactic measures among VFRs. Basic
knowledge has been associated with using prophylactic
measures [17]. Incorrect knowledge of malaria has been
also reported [18-20]. Accurate risk perception (people’s
subjective assessment of the risk of malaria) has been
described [18,19,21], and associated with using prophylac-
tic measures [17,22]. Attitudes towards using prophylaxis
(the degree to which one is in favour or against personally
using preventive measures) have also been found to in-
fluence use of preventive measures [17,18,20-22]. How-
ever, determinants that can be influenced to improve
uptake of malaria prophylaxis among VFRs travelling to
West Africa are still to be identified.
The aim of this research was to quantitatively assess which
determinants explain uptake of malaria chemoprophylaxis
(starting and buying of chemoprophylaxis and obtaining
pre-travel advice) among West African VFRs.
Methods
For this cross-sectional observational study, questionnaires
were administered to VFRs travelling to West Africa.
A five- to ten-minute questionnaire was constructed and
administered to travellers waiting at Schiphol International
Airport, Amsterdam, at the boarding gates of flights
to Kotoka International Airport, Accra (Ghana). Two
researchers (PB and RWW) approached, at random, as
many persons as possible during the waiting time at the
gates for each flight (usually around two hours), and asked
whether they were willing to answer the questions that
would take five to ten minutes. Interviews took place dur-
ing a period of 11 days in July 2012. The software program
QuickTapSurvey (TabbleDabble, Toronto, Canada, 2011)
was installed on mobile handheld computers to collect
and store data.
Effective chemoprophylaxis (e g, atovaquone/proguanil,
doxycycline or mefloquine) should be started on the
day of departure or earlier. In this study, three outcome
measures for uptake of chemoprophylaxis were used:
(1) whether chemoprophylaxis had been started on the
day of or before departure; (2) whether chemoprophylaxis
had been bought; and, (3) whether pre-travel advice had
been obtained. These behaviours were investigated with
questions that could be answered with yes or no. Thetarget population consisted of travellers aged >17 years.
The analysis included travellers who had been living
outside of West Africa for at least one year and were
born in West Africa or of whom at least one parent was
born in West Africa.
Group size was calculated according to the number of
predictors in the logistic regression model. The largest
number of participants would be needed if 50% of travellers
had started chemoprophylaxis. If at least seven determi-
nants would be added in the model and 10 participants
per determinant would be required [23], 10 × 7 × 2 = 140
participants would be the absolute minimum.
Variables
In order to assess personal variables, data on demographic
details (sex, age, country of residence, country of birth,
date of departure from country of birth), travel details
(travel purpose, destination and duration of travel) and
previous experience (whether travellers had contracted
malaria before) were collected.
Education was not included because among the inter-
national population, many different schooling systems
exist and this was not a uniform measure of knowledge.
To select and specify determinants to be included in the
questionnaire, eight in-depth interviews with Ghanaians of
various socio-economic backgrounds living in Amsterdam
were conducted. Topics discussed were malaria, taking
prophylactic measures, and making travel preparations.
The determinants potentially influencing the use of
chemoprophylaxis were identified and arranged in a
model (Figure 1) based on three behavioural theories;
the Theory of Planned Behaviour (TPB) [24], the Health
Belief Model (HBM) [25], and the Protection Motivation
Theory (PMT) [26]. The questions to assess behavioural
determinants are shown in the Additional file 1. Statis-
tical analyses were performed using PASWstatistics19
(IBM, Chicago, IL, USA).
Analysis
In order to assess the relationship between the three
prophylactic behaviours and VFRs’ demographics, previous
malaria experience and travel details, univariate analyses
were carried out. For binomial outcomes chi-square tests;
for normally distributed continuous outcomes Student’s
t tests; and for non-parametric continuous outcomes,
Mann Whitney U tests were used.
On theoretical grounds, reliability analyses (assessment
of internal consistency) were applied in order to construct
determinant scales using the Cronbach’s alpha statistic. This
resulted in low values of internal consistency [27]: 0.49 for
knowledge, 0.17 for attitudes, 0.23 for risk perception,
0.38 for social influence, 0.36 for perceived behavioural
control, and −0.42 for barriers. Therefore, the questions
were analysed as separate variables.
Figure 1 Behavioural model for obtaining pre-travel advice, buying anti-malarial tablets and starting anti-malarial tablets. Experience
includes experience of disease, of the use of chemoprophylaxis and previous travel. Personality variables include demographics and travel details.
Social includes social support and model behaviour. Determinants were structured based on three behavioural models. The Theory of Planned
Behaviour (TPB) includes external variables (demographics, personality traits and environmental influences), attitudes (whether people regard a
given behaviour positively or negatively), subjective norms (what the social environment thinks about the behaviour and how it acts) and
perceived behaviour control (PBC) (expected personal performance of behaviour) as determinants. These determinants influence intention to
perform behaviour, and intention predicts whether behaviour is performed. In the Health Belief Model (HBM), motivation to perform behaviour,
perceived health threat and perceived reduction of this threat determine whether a given behaviour is performed. The Protection Motivation
Theory (PMT) includes perceived severity of a threatening event, vulnerability of individuals (the chance that the health threat will occur), efficacy
of recommended preventive behaviour and self-efficacy (defined as PBC in the TPB). This theory includes previous behaviour as an
additional determinant.
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prophylactic behaviours, a block-wise logistic regression
analysis for each of the three outcome variables was
carried out. Due to the small sample size, the number
of determinants (independent variables) included was
restricted. For this reason, variables were selected as
described below.
The first block included independent variables that had
a significant influence (p value <0.05) on the outcome
measure in univariate analyses. Two of these variables
(age and time of departure from country of birth) were
highly correlated with each other (Pearson’s correl-
ation -.718, p = <0.01). In a clinical setting, risk groups
based on age were regarded to be easier to work with,
therefore year of departure from country of birth was
excluded from the logistic regression model.
The second block included determinants in the regres-
sion model that significantly correlated (p-value of <0.10)
with the dependent variables in a bivariate Pearson’s
correlation analysis (Additional file 2). The third block
included previous use of chemoprophylaxis if it correlated
with the outcome measure (Pearson’s correlation <0.10,
Additional file 2).Results
Participants
There was an approximate rejection rate of 10%. Out of a
total of 164 participants recruited, 154 met both inclusion
and exclusion criteria. The completion rate was 100%. As
shown in Table 1, 81/154 (52.6%) participants were male.
The mean age was 40.8 (SD 12.7); 82/154 (53.2%) were living
in North or Central America and 72/154 (46.8%) in Europe.
The main travel purpose was family affairs (134/154; 87.0%).
Preventive behaviour
The majority (124/154; 80.5%) had used chemoprophylaxis
before. Eighty-three VFRs (53.9%) had started chemo-
prophylaxis, 93 (60.4%) had bought chemoprophylaxis
and pre-travel advice had been obtained by 104 VFRs
(67.5%). Those who had obtained pre-travel advice were
more likely to have bought and started chemoprophylaxis
(bought: r 0.58, p = <0.01, started:, r 0.60, p = <0.01)
(Additional file 2).
Behavioural determinants
Details regarding behavioural determinants can be found
in Additional file 2.




CP N = 83
% Not started
CP N = 71
% RR [CI] p-value
Sex, N (%) a
Male 81 (52.6) 38 (45.8) 43 (60.6) 0.76 [0.56-1.02] 0.067
Age, N (%) b
Mean 40.8 42.6 38.8 0.033
SD 12.7 12.8 12.4
Missing N (%) 9 (5.8)
Country of residence a 1.22 [0.91-1.64]
North and Central America, N (%) 82 (53.2) 40 (48.2) 42 (59.2) 0.17
Europe, N (%) 72 (46.8) 43 (51.8) 29 (40.8)
Country of birth in West Africac 0.76 [0.51-1.13]
Ghana, N (%) 133 (86.4) 71 (85.5) 62 (87.3) 0.246
Other West African country1, N (%) 8 (5.2) 3 5
(3.6) (7.0)
Outside West Africa, N (%) 13 (8.4) 9 (10.8) 4 (5.6)
Departure country of birth (Y) b
Median 1997 1993 2001
Interquartile range 1990-2002 1989-1999 1992-2007 <0.001
Traveller VFRs, N (%) 13 (8.4)
Previous visit, N (%)a 139 (90.3) 78 (94.0) 61 (90.0) 1.35 [0.68-2.67] 0.09
Had malaria before a
Yes, N (%) 85 (55.2) 37 (50.0) 48 (71.6) 0.66 [0.48-0.89] <0.001
No, N (%) 56 (36.4) 37 19 (28.4)
Missing, N (%) 13 (8.4) (50.0)
Travel purpose, family affairs a
Family affairs2, N (%) 134 (87.0) 78 (94.0) 56 (78.9) 2.33 [1.08-5.04] 0.005
Other3, N (%) 20 (13.0) 5 (6.0) 15 (21.1)
Period West Africa >6 weeks a
<6 weeks, N (%) 119 (77.3) 76 (91.6) 43 (63.2) 0.34 [0.18-0.67] <0.001
>6 weeks, N (%) 32 (20.8) 7 25
Missing, N (%) 3 (1.9) (8.4) (36.8)
CP = chemoprophylaxis, RR = Relative risk, a p-value calculated using the chi-square test; b p-value calculated using the Mann–Whitney U test; c p-value calculated
comparing those born in West Africa to those born outside West-Africa using chi square test.
Significant differences are indicated in boldface.
1 Other countries of birth in West Africa were: Nigeria (three), Liberia (two), Cote d’Ivoire (one), Togo (one) and Sierra Leone (one).
2 Family affairs comprise VFR travel, funerals and weddings.
3 Other travel purposes are business (ten), holiday (four) and other (six).
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Most participants knew malaria was transmitted by mosqui-
toes, however many misperceptions existed (e g, about trans-
mission via contaminated food and contact with infected
people, and about being vaccinated against malaria).
Attitudes
A majority of VFRs were not afraid of side effects of tablets
and did not think curing malaria is easier than taking pre-
ventive tablets. Overall, respondents had faith in malaria
tablets and felt that it is bad to use tablets for a long time.Risk perception
Overall, a slight minority of VFRs thought they were
immune for malaria. Most participants recognized the
risk of infection in the area they were travelling to and that
people can die from the disease. However, personal risk
was perceived to be lower than the risk of others.
Social influence
Most VFRs answered that their friends and/or family
used tablets, and that these social contacts encouraged
rather than discouraged them to use tablets.
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Most participants felt well informed about malaria.
Many VFRs thought they could forget a tablet, but
most of them did not think the tablet schedule was
a difficult regime to follow.
Barriers
A minority answered that they had had difficulties with
the tablets. Most participants reported to have had
enough time to prepare for travel and had to pay for tab-
lets themselves. Swallowing tablets was not regarded a
problem by most VFRs.
Groups at risk
Higher age and travelling for family purposes were
positively associated with all behaviours (Block 1; Table 2).Table 2 Logistic regression analyses of determinants predicti





Age (y) 0.004 1.067 0.005
Travel purpose 0.022 8.906 0.030
Previous malaria 0.028 0.265 0.008
> 6 weeks in West Africa 0.001 0.046 0.000
<0.01 0.55
K2 food - - 0.514
K3 contact - - 0.431
K6 vaccinated 0.009 4.467 0.017
A1 afraid 0.460 0.810 -
A3 faith 0.221 1.824 -
A4 cure easier than tablets 0.046 0.499 0.023
R4 immune - - 0.225
S2 encourage 0.867 0.947 0.682
S3 discourage 0.240 0.608 -
PBC 1 forgot tablet 0.752 1.091 -
PBC 2 regime hard 0.090 0.592 -
0.14 0.56
E1 used in past 0.139 3.707 0.800
Constant 0.322 0.056 0.641
Nagelkerke R = explained variance of the block with included determinants [28].
K2: Determinant Knowledge 2, is malaria transmitted by contaminated food?
K3: Determinant Knowledge 3, is malaria transmitted by infected people?
K6: Determinant Knowledge 6, are you vaccinated against malaria?
A1: Determinant Attitude 1, I am afraid of side effects.
A3: Determinant Attitude 3, I have faith in malaria tablets.
A4: Determinant Attitude 4, it is easier to cure malaria than take tablets.
R4: Determinant Risk perception 4, I am immune for malaria.
S2: Determinant Social 2, my friends/ family encourage use of tables.
S3: Determinant Social 3, my friends/ family discourage use of tablets.
PBC 1: Determinant Perceived Behaviour Control 1, I think I could forget a tablet.
PBC 3: Perceived Behaviour Control 3, do you feel well informed of malaria.
E1: Determinant Previous experience, have you used tablets in the past?
Significant outcomes are indicated in boldface.Having had malaria and spending more than six weeks in
West Africa were negatively associated with starting and
buying chemoprophylaxis.
Influential determinants
The more respondents agreed that curing malaria is easier
than taking preventive tablets, the less likely they were
to have started (OR 0.499, p = 0.046) and bought chemo-
prophylaxis (OR 0.471, p = 0.023), and to have obtained
pre-travel advice (OR 0.297, p = 0.001; Block 2; Table 2).
The more convinced respondents were that they had
been vaccinated, the more likely they were to have started
chemoprophylaxis (OR 4.467, p = 0.009) and to have
bought chemoprophylaxis (OR 4.161, p = 0.017).
Respondents who were more convinced that mal-
aria can be transmitted by infected people were moreng prophylactic behaviour
t CP N = 122 Obtained pre-travel advice N = 128
OR Sig
Block
Nagelkerke R Sig. OR Sig
Block
Nagelkerke R
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p = 0.035).
Previous behaviour
Previous use of chemoprophylaxis did not influence current
preventive behaviour (Block 3; Table 2).
Factors correlating with influential determinants
Correlations of behavioural determinants can be found
in Additional file 2. Respondents who felt it is easier to
cure than to prevent malaria (A4) more often thought
that their friends and family discouraged the use of
chemoprophylaxis (S3, r 0.25, p < 0.01). They also less
often reported to have faith in malaria tablets (A3, r
−0.19, p = 0.02), less often felt well informed about mal-
aria (PBC3, r = −0.20, p = 0.02) and were less likely to
have used tablets in the past (E2, r-.26, p < 0.01). Those
who thought malaria is transmitted by infected people
(K3) more often thought that malaria is transmitted by
food (K2, r .66, p < 0.01), that there is a vaccine available
(K5, r = .27, p = <0.01,) and that they were vaccinated
against malaria (K6, r = 0.32, p < 0.01). They less often felt
well informed about malaria (PBC3, r = −0.14, p = 0.09) and
reported to have had difficulties with tablets (B1, r = −0.22,
p = 0.02) less often.
Respondents who assumed they had been vaccinated
(K6) were more likely to incorrectly think a vaccine was
available (K5, r = 0.33, p = <0.01), that malaria is transmitted
by contaminated food (K2, r = 0.36, p = <0.01) and that
malaria is transmitted by infected people (K3, r = 0.32,
p = <0.01). They were less likely to think that malaria is a
problem in West Africa (R1, r = −0.19, p = 0.02) and had
difficulties with tablets less often (B1, r = −0.21, p = 0.02).
Discussion
Preventive behaviour and specific risk groups
The study sample performed reasonably well compared to
previous reports: 53.9% had started chemoprophylaxis,
60.4% had bought chemoprophylaxis and 67.5% had
obtained pre-travel advice. Previously, percentages ranging
from 14 to 32% for starting chemoprophylaxis, of
17.6% for buying chemoprophylaxis and of 13.4% for
obtaining pre-travel advice have been reported among
VFRs [13,17,19,21,22]. However, the fact remains that
almost half of the VFRs visited a high-risk destination
without adequate protection. Young VFRs, those trav-
elling for longer periods, those travelling for business
and those who had had malaria were least likely to use
preventive measures against malaria. Those travelling
for longer periods [17] and those travelling for business
[20,21] have been recognized as risk groups. Previous
studies were less conclusive regarding the positive rela-
tionship between age and the use of chemoprophylaxis
[17,21,22] or taking vaccinations [20]. The previouslyobserved positive relationship between attendance to
travel clinics and use of malaria chemoprophylaxis is
confirmed with these findings [19-21]. Therefore, in-
crease of attendance of specific risk groups to a travel
clinic might be a first step in improving uptake of malaria
prophylaxis.
Determinants - role of attitudes and risk perception
An important determinant that explained preventive
behaviour was the opinion that curing malaria is easier
than the use preventive tablets. Based on the inter-
views, this item was included as a measure of VFRs’
general attitude towards prevention of malaria. To
properly interpret this determinant however, it should
be considered a double-barrelled question, which
touches upon two issues that can be modelled accor-
ding to the PMT [26]. In PMT, behavioural change will
occur following threat appraisal (severity of the disease
and vulnerability to the disease) if the coping appraisal
(self efficacy and response efficacy) is sufficiently high.
‘Curing the disease is easy’ may reflect perceived sever-
ity of the disease, as one component of perceived risk
[26,29]. ‘Taking tablets is easy’ may mirror perceived
behaviour control (or self efficacy) with regard to
taking preventive tablets [24].
The perception of malaria as an easily treatable disease
(perceived severity) was, similar to findings described
here, negatively related to the uptake of and adherence
to malaria prophylaxis in two previous studies [17,18].
Regarding vulnerability (risk perception items), no
relationship with uptake of malaria prophylaxis was
found. In contrast, the two other studies did find a
negative relationship between low perceived personal
risk of getting malaria and the use of malaria prophylaxis
[17,18]. This apparent incongruence may be explained by
the fact that accurate risk perception leads to behaviour
change only if both response efficacy and self-efficacy are
sufficiently high [26,29].
Previous findings that response efficacy and self-efficacy
may be low [18,21], were confirmed by the present study.
That is, travellers who had the opinion that it is easier to
cure malaria were also less likely to have faith in the effect-
iveness of malaria tablets (response efficacy), felt less in-
formed about malaria and were less likely to have used
tablets in the past (self efficacy).
These results indicate that behaviour change strategies
to optimize the use of malaria chemoprophylaxis amongst
VFRs should preferably focus on increasing response
efficacy (faith in malaria tablets) and additionally pay
attention to VFRs’ self efficacy. VFRs who were inclined to
think that curing malaria was easier than to use preventive
tablets more often felt discouraged to use chemoprophy-
laxis by their family and friends. Therefore behaviour
change strategies could include friends and family members
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change methods in this respect are role modelling and
social comparison [30].
Determinants - role of knowledge and incorrect
knowledge
Better knowledge did not improve the use of preventive
measures. Surprisingly, VFRs who incorrectly assumed they
had been vaccinated against malaria were more likely to
have started and bought chemoprophylaxis. This finding is
comparable with previously found erroneous beliefs about
immunity [17] and the availability of a malaria vaccine [19].
In this study, the incorrect assumption of being vaccinated
was associated with other incorrect beliefs, such as that
malaria can be transmitted by contaminated food and
by infected people.
These findings can be explained in two ways. First,
according to the TPB, information accuracy is neither
necessary nor sufficient for behaviour change [31]. Ac-
tions are determined by subjectively held information
(i e, beliefs, either correct or incorrect) rather than by
accurate information [31]. Risk reduction strategies should
therefore not focus on correcting erroneous knowledge
as a purpose in itself. Second, the relationship between
incorrectly assuming to be vaccinated and starting
chemoprophylaxis might be explained by the fact that
during the visit to a pre-travel clinic both a vaccination
(against yellow fever) and malaria tablets are provided.
Confusion between yellow fever vaccination and mal-
aria prophylaxis in African travellers living in Paris and
London has been described [18,19]. Future qualitative
research could focus on what exactly happens during
pre-travel consultations, to assess whether or not they
interfere with the response efficacy and self efficacy-
enhancing strategies recommended above.
Limitations of the study
This study has several limitations. One is the relatively
small study population, compromising statistical analysis.
Due to the fact that more than half the VFRs were transit
passengers, country of residence varied. Possibly, attitudes
about prevention vary between those coming from
Central/North America and Europe. Also, this cross-
sectional study was merely a snapshot of the situation
without a longitudinal follow-up regarding adherence
to prophylaxis regimes. It should be noted that it was
not checked whether participants carried the tablets they
reported. As confusion about preventive drugs among trav-
ellers has been described (e g, paracetamol was mistakenly
reported as a malaria preventive drug [20]), the percentages
of having bought and started chemoprophylaxis may be too
optimistic. Because of time constraints the number of ques-
tions in the questionnaire had to be minimized. Internally
consistent determinant scales could not be constructed.This indicates that the beliefs measured did not entirely
cover the theoretical determinants under consideration.
Thanks to the preceding qualitative enquiry, however, the
questionnaire presumably included the most salient beliefs.
Age was included in the model instead of migration
time. This may be debatable as information for public
health measures may be lost; however, as pre-travel ad-
vice is provided in a clinical setting this variable was
preferred. Finally, as not all participants fully mastered
the English language, some questions might have been
misunderstood.
Conclusion
This study population performed relatively well compared
to other VFR populations as more than half had started
chemoprophylaxis. However, improvements remain ne-
cessary and prevention strategies should focus on young
travellers, business travellers, long-term travellers and those
who have previously experienced malaria. Pre-travel consul-
tations should not aim to correct erroneous beliefs about
malaria as such. Preventive strategies should focus on in-
creasing response efficacy (e g, the effectiveness of malaria
prophylaxis) and self-efficacy (related to the complexity of
the medication regime). Such strategies could be strength-
ened by including friends and family members to create
the positive social environment needed to further improve
the use of malaria prophylaxis.
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